Search by Drug Name or NDC

    NDC 72974-0120-97 Orgovyx 120 mg/1 Details

    Orgovyx 120 mg/1

    Orgovyx is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sumitomo Pharma America, Inc. The primary component is RELUGOLIX.

    Product Information

    NDC 72974-0120
    Product ID 72974-120_2ec7524a-0548-48eb-b59b-09fbe985f8ea
    Associated GPIs 21405570000320
    GCN Sequence Number 081783
    GCN Sequence Number Description relugolix TABLET 120 MG ORAL
    HIC3 V1V
    HIC3 Description ANTINEOPLASTIC LHRH(GNRH) ANTAGONIST,PITUIT.SUPPRS
    GCN 49005
    HICL Sequence Number 047035
    HICL Sequence Number Description RELUGOLIX
    Brand/Generic Brand
    Proprietary Name Orgovyx
    Proprietary Name Suffix n/a
    Non-Proprietary Name relugolix
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 120
    Active Ingredient Units mg/1
    Substance Name RELUGOLIX
    Labeler Name Sumitomo Pharma America, Inc
    Pharmaceutical Class Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased GnRH Secretion [PE], Gonadotropin Releasing Hormone Receptor Antagonist [EPC], Gonadotropin Releasing Hormone Receptor Anta
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA214621
    Listing Certified Through 2024-12-31

    Package

    NDC 72974-0120-97 (72974012097)

    NDC Package Code 72974-120-97
    Billing NDC 72974012097
    Package 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-120-97)
    Marketing Start Date 2021-10-21
    NDC Exclude Flag N
    Pricing Information N/A